Ординатура / Офтальмология / Английские материалы / Electrophysiology of Vision_Lam_2005
.pdf268 |
Chapter 9 |
Drescher B, Sauer CG, Zrenner E, Meitinger T, Rosenthal A, Meindl A. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 1998; 19:260–263.
16.Nakamura M, Ito S, Terasaki H, Miyake Y. Novel CACNA1F mutations in Japanese patients with incomplete congenital stationary night blindness. Invest Ophthalmol Vis Sci 2001; 42:1610–1616.
17.Ruether K, Apfelstedt-Sylla E, Zrenner E. Clinical findings in patients with congenital stationary night blindness of the Schubert–Bornschein type. Ger J Ophthalmol 1993; 2: 429–435.
18.Khouri G, Mets MB, Smith VC, Wendell M, Pass AS. X-linked congenital stationary night blindness. Review and report of a family with hyperopia. Arch Ophthalmol 1988; 106: 1417–1422.
19.Pearce WG, Reedyk M, Coupland SG. Variable expressivity in X-linked congenital stationary night blindness. Can J Ophthalmol 1990; 25:3–10.
20.Boycott KM, Pearce WG, Bech-Hansen NT. Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F. Can J Ophthalmol 2000; 35:204–213.
21.Tremblay F, LaRoche RG, De Becker I. The electroretinographic diagnosis of the incomplete form of congenital stationary night blindness. Vision Res 1995; 35:2383–2393.
22.Miyake Y, Yagasaki K, Horiguchi M, Kawase Y. Onand offresponses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol 1987; 31:81–87.
23.Quigley M, Roy M-S, Barsoum-Homsy M, Chevrette L, Jacob J-L, Milot J. Onand off-responses in the photopic electroretinogram in complete-type congenital stationary night blindness. Doc Ophthalmol 1996; 92:159–165.
24.Miyake Y, Horiguchi M, Terasuki H, Kondo M. Scotopic threshold response in complete and incomplete types of
Stationary Night Blindness and Stationary Cone Dysfunction Disorders |
269 |
congenital stationary night blindness. Invest Ophthalmol Vis Sci 1994; 35:3770–3775.
25.Kamiyanna M, Yamamoto S, Nitta K, Hayasaka S. Undetectable S cone electroretinogram b-wave in complete congenital stationary night blindness. Br J Ophthalmol 1996; 80: 637–639.
26.Terasaki H, Miyake Y, Nomura R, Horiguchi M, Suzuki S, Kondo M. Blue-on-yellow perimetry in the complete type of congenital stationary night blindness. Invest Ophthalmol Vis Sci 1999; 40:2761–2764.
27.Kondo M, Miyake Y, Kondo N, Tanikawa A, Suzuki S, Hortguchi M, Terasaki H. Multifocal ERG findings in complete type congenital stationary night blindness. Invest Ophthalmol Vis Sci 2001; 42:1342–1348.
28.Miyake Y, Kawase Y. Reduced amplitude of oscillatory potentials in female carriers of x-linked recessive congenital stationary night blindness. Am J Ophthalmol 1984; 98: 208–215.
29.Rigaudiere F, Roux C, Lachapelle P, Rosolen SG, Bitoun P, Gay-Duval A, Le Gargasson JF. ERG in female carriers of incomplete congenital stationary night blindness. Doc Ophthalmol 2003; 107:203–212.
30.Ruttum MS, Lewandowski MF, Bateman JB. Affected females in X-linked congenital stationary night blindness. Ophthalmology 1992; 99:747–752.
31.Bech-Hansen NT, Pearce WG. Manifestations of X-linked congenital stationary night blindness in three daughters of an affected male: demonstration of homozygosity. Am J Hum Genet 1993; 52:71–77.
32.Riggs LA. Electroretinography in cases of night blindness. Am J Ophthalmol 1954; 38:70–78.
33.Auerbach E, Godel V, Rowe H. An electrophysiological and psychophysical study of two forms of congenital night blindness. Invest Ophthalmol 1969; 8:332–345.
34.Francois J, Varriest G, de Rouck A, Dejean C. Les fonctions visuelles dans I’hemaralopie essentielle nougarienne. Ophthalmologica 1956; 132:244–257.
270 |
Chapter 9 |
35.Dryja TP, Hahn LB, Reboul T, Arnaud B. Missense mutation in the gene encoding the alpha-subunit of rod transducin in Nougaret form of congenital stationary night blindness. Nat Genet 1996; 13:358–360.
36.Sandberg MA, Pawlyk BS, Dan J, Arnaud B, Dryja TP, Berson EL. Rod and cone function in the Nougaret form of stationary night blindness. Arch Ophthalmol 1998; 116:867–872.
37.Rosenberg T, Haim T, Piczenik Y, Simonsen SE. Autosomal dominant stationary night-blindness. A large family rediscovered. Acta Ophthalmol 1991; 69:694–702.
38.Gal A, Orth U, Baehr W, Schwinger E, Rosenberg T. Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness. Nat Genet 1994; 7:64–68.
39.Dryja TP, Berson EL, Rao VR, Oprian DD. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet 1993; 4:280–283.
40.Sieving PA, Richards JE, Naarendorp F, Bingham EL, Scott K, Alpern M. Dark-light model for night blindness from the human rhodopsin Gly-90-Asp mutation. Proc Natl Acad Sci USA 1995; 92:880–884.
41.al-Jandal N, Farrar GJ, Kiang AS, Humphries MM, Bannon N, Findlay JB, Humphries P, Kenna PF. A novel mutation within the rhodopsin gene (Thr-94-Lle) causing autosomal dominant congenital stationary night blindness. Hum Mutat 1999; 13:75–81.
42.Forsius H, Eriksson AW. Ein neues Augensyndrom mit X- chromosomaler Transmission: eine Sippe mit Fundusalbinismus, Foveahypoplasie, Nystagmus, Myopie, Astigmatismus und Dyschromatopsie. Klin Mbl Augenheilk 1964; 144: 447–457.
43.Hawksworth NR, Headland S, Good P, Thomas NS, Clarks A. Aland island eye disease: clinical and electrophysiological studies of a Walsh family. Br J Ophthalmol 1995; 79:424–430.
44.Barnes CS, Alexander KR, Fishman GA. A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction. Ophthalmology 2002; 109:575–583.
Stationary Night Blindness and Stationary Cone Dysfunction Disorders |
271 |
45.Carr RE, Ripps H, Siegel IM, Weale RA. Rhodopsin and the electrical activity of the retina in congenital night blindness. Invest Ophthalmol Vis Sci 1966; 5:497–507.
46.Krill AE, Martin D. Photopic abnormalities in congenital stationary night blindness. Invest Ophthalmol 1971; 10:625–636.
47.Takahashi Y, Onoe S, Asamizu N, Mori T, Yoshimura Y, Tazawa Y. Incomplete congenital stationary night blindness: electroretinogram c-wave and electrooculogram light rise. Doc Ophthalmol 1988; 70:67–75.
48.Tremblay F, De Becker I, Cheung C, LaRoche R. Visual evoked potentials with crossed asymmetry in incomplete congenital stationary night blindness. Invest Ophthalmol Vis Sci 1996; 37:1783–1792.
49. Yamamoto H, Simon A, Eriksson U, Harris E, Berson EL, Dryja TP. Mutation in the gene encoding 11-cis retinal dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet 1999; 22:188–191.
50.Wada Y, Abe T, Fuse N, Tamai M. A frequent 1085delC= insGAAG mutation in the RDH5 gene in Japanese patients with fundus albipunctatus. Invest Ophthalmol Vis Sci 2000; 41:1894–1897.
51.Carr R, Ripps H, Siegel IM. Visual pigment kinetics and adaptation in fundus albipunctatus. Doc Ophthalmol Proc Ser 1974; 4:193–204.
52.Marmor MF. Long-term follow-up of the physiologic abnormalities and fundus changes in fundus albipunctatus. Ophthalmology 1990; 97:380–384.
53.Nakazawa M, Hotta Y, Tanikawa A, Terasaki H, Miyake Y. A high association with cone dystrophy in fundus albipunctatus caused by mutations of the RDH5 gene. Invest Ophthalmol Vis Sci 2000; 41:3925–3932.
54.Nakamura M, Skalet J, Miyake Y. RDH5 gene mutations and electroretinogram in fundus albipunctatus with or without macular dystrophy. Doc Ophthalmol 2003; 107:3–11.
55.Margolis S, Siegel I, Ripps H. Variable expressivity in fundus albipunctatus. Ophthalmology 1987; 94:1416–1422.
272 |
Chapter 9 |
¨
56. Oguchi C. Uber eine Abart von Hemeralopie. Acta Soc Ophtalmol Jpn 1907; 11:123–134.
57. Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 1995; 10:360–362.
58. Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 1997; 15:175–178.
59. Nakazawa M, Wada Y, Tamai M. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch Ophthalmol 1998; 116:498–501.
60. Yoshi M, Murakami A, Akeo K, Nakamura A, Shimoyama M, Ikeda Y, Kikuchi Y, Okisaka S, Yanashima K, Oguchi Y. Visual function and gene analysis in a family with Oguchi’s disease. Ophthalmic Res 1998; 30:394–401.
61. Nakamachi Y, Nakamura M, Fujii S, Yamamoto M, Okubo K. Oguchi disease with sectoral retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin gene. Am J Ophthalmol 1998; 125:249–251.
62. Kubota Y. The oscillatory potentials of the ERG in Oguchi’s disease. Doc Ophthal Proc Ser 1974; 10:317–324.
63. Miyake Y, Horiguchi M, Suzuki S, Kondo M, Tanikawa A. Electrophysiological findings in patients with Oguchi’s disease. Jpn J Ophthalmol 1996; 40:511–519.
64. Yamamoto S, Hayashi M, Takeuchi S, Shirao Y, Kita K, Kawasaki K. Normal S cone electroretinogram b-wave in Oguchi’s disease. Br J Ophthalmol 1997; 81:1043–1045.
65. Carr RE, Gouras P. Oguchi’s disease. Arch Ophthalmol 1965; 73:646–656.
66. Carr RE, Ripps H. Rhodopsin kinetics and rod adaptation in Oguchi’s disease. Invest Ophthalmol 1967; 6:426–436.
67. Kandori F, Tamai A, Kurimoto S, Fukunaga K. Fleck retina. Am J Ophthalmol 1972; 73:673–685.
Stationary Night Blindness and Stationary Cone Dysfunction Disorders |
273 |
68.Okamoto M, Okajima O, Tanino T. The early receptor potential in the human eye. III. ERP in dichromats. Jpn J Ophthalmol 1982; 26:23–28.
69.Kawasaki K, Yonemura D, Nakazato H, Kawaguchi I. Abnormal spectral sensitivity of the electroretinographic offresponse in protanopia and protanomalia. Doc Ophthalmol 1982; 53:51–60.
70.Nakazato H, Hanazaki H, Kawasaki K, Tanabe J, Yonemura D. Electroretinographic off-response in congenital red-green color deficiency and its genetic carrier. Doc Ophthalmol 1986; 63:179–186.
71.Shinzato K, Yokoyama M, Uji Y, Ichikawa H. The electroretinographic characteristics of congenital tritan defects. Doc Ophthalmol 1986; 62:19–24.
72.Kohl S, Baumann B, Broghammer M, Jagle H, Sieving P, Kellner U, Spegal R, Anastasi M, Zrenner E, Sharpe LT, Wissinger B. Mutations in the CNGB3 gene encoding the beta subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet 2000; 9:2107–2116.
73.Kohl S, Marx T, Giddings I, Jagle H, Jacobson SG, ApfelstedtSylla E, Zrenner E, Sharpe S, Wissinger B. Total colour blindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet 1998; 19:257–259.
74.Wissinger B, Gamer B, Jagle H, Giorda R, Marx T, Tippmann S, Broghammer M, Jurklies B, Rosenberg T, Jacobson SG, Sener EC, Tatlipinar S, Hoyng CB, Castellan C, Bitoun P, Andreasson S, Rudolph G, Kellner U, Lorenz B, Wolff G, Verellen-Dumoulin C, Schwartz M, Cremers FP, ApfelstedtSylla E, Zrenner E, Salati R, Sharpe LT, Kohl S. CNGA3 Mutations in hereditary cone photoreceptor disorders. Am J Hum Genet 2001; 69:722–737.
75.Pokorny J, Smith VC, Pinckers AJ, Cozijnsen M. Classification of complete and incomplete autosomal recessive achromatopsia. Graefes Arch Clin Exp Ophthalmol 1982; 219:121–130.
76.Nathans J, Davenport CM, Maumenee IH, Lewis RA, Hejtmanik JF, Litt M, Lovrien E, Weleber R, Bachynski B,
274 |
Chapter 9 |
Zwas F, Klingaman R, Fish G. Molecular genetics of human blue cone monochromacy. Science 1989; 245:831–838.
77.Wang Y, Macke JP, Merbs SL, Zack DJ, Klaunberg B, Bennett J, Gearhart J, Nathans J. A locus control region adjacent to the human red and green visual pigment genes. Neuron 1992; 9:429–440.
78.Ayyagari R, Kakuk LE, Bingham EL, Szczesny JJ, Kemp J, Toda Y, Felius J, Sieving PA. Spectrum of color gene deletions and phenotype in patients with blue cone monochromacy. Hum Genet 2000; 107:75–82.
79.Ladekjaer-Mikkelsen AS, Rosenberg T, Jorgensen AL. A new mechanism in blue monochromatism. Hum Genet 1996; 98:403–408.
80.Nathans J, Maumenee IH, Zrenner E, Sadowski B, Sharpe LT, Lewis RA, Hansen E, Rosenberg T, Schwartz M, Heckenlively JR, Traboulsi E, Klingaman R, Bech-Hansen NT, LaRoche RG, Pagon RA, Murphey WH, Weleber RG. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet 1993; 53:987–1000.
81.Reyniers E, Van Thienen M-N, Meire F, Boulle KD, Devries K, Kestelijn P, Willems PJ. Gene conversion between red and defective green opsin gene in blue cone monochromacy. Genomics 1995; 29:323–328.
82.Ayyagari R, Kakuk LE, Coats CL, Bingham EL, Toda Y, Felius J, Sieving PA. Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol Vis 1999; 5:13.
83.Fleischman JA, O’Donnell REJ. Congenital X-linked incomplete achromatopsia: evidence for slow progression, carrier fundus findings, and possible genetic linkage with glucose-6- phosphate dehydrogenase locus. Arch Ophthalmol 1981; 99:468–472.
84.Gouras P, Mackay CJ, Lewis AL. The blue cone electroretinogram isolated in sex-linked achromat. In: Drum B, Verriest G, eds. Color Vision Deficiencies. Dordrecht: Kluwer, 1989:9:89–93.
Stationary Night Blindness and Stationary Cone Dysfunction Disorders |
275 |
85.Berson EL, Sandberg MA, Rosner B, Sullivan PL. Color plates to help identify patients with blue cone monochromatism. Am J Ophthalmol 1983; 95:741–747.
86.Pinckers A. Berson test for blue cone monochromatism. Int Ophthalmol 1992; 16:185–186.
87. Wiess AH, Biersdorf WR. Blue cone monochromatism. J Pediatr Ophthalmol Strabismus 1989; 26:218–223.
88.Alpern M, Lee GB, Maaseidvaag F, Miller SS. Colour vision in blue-cone monochromacy. J Physiol 1971; 212:211–233.
89.Blackwell HR, Blackwell OM. Rod and cone receptor mechanisms in typical and atypical congenital achromatopsia. Vision Res 1961; 1:62–107.
90.Pokorny J, Smith VC, Swartley R. Threshold measurements of spectral sensitivity in a blue monocone monochromat. Invest Ophthalmol 1970; 9:807.
91.Ikeda H, Ripps H. The electroretinogram of the cone monochromat. Arch Ophthalmol 1966; 75:513–517.
92.Gottlob I. Eye movement abnormalities in carriers of bluecone monochromatism. Invest Ophthalmol Vic Sci 1994; 35: 3556–3660.
93.Berson EL, Sandberg MA, Maguire A, Bromley WC, Roderick TH. Electroretinograms in carriers of blue cone monochromatism. Am J Ophthalmol 1986; 102:254–261.
94.Terasaki H, Miyake Y. Japanese family with blue cone monochromatism. Jpn J Ophthalmol 1992; 36:132–141.
95.Sieving PA. Photopic ONand OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 1993; 91: 701–703.
96.Lam BL. Hereditary retinal degenerations. In: Parrish R, ed. Bascom Palmer Eye Institute Atlas of Ophthalmology. Philadelphia: Current Medicine, 2000:343–349.
10
Macular Disorders
A number of retinal disorders preferentially involve the macula or have distinct macular characteristics. Electrophysiologically, the multifocal ERG provides topographical information and is a useful objective measure of macular function. Although the focal ERG can also assess macular dysfunction, the popularity and availability of focal ERG are diminished with advances in multifocal ERG. An isolated macular lesion is unlikely to reduce the overall ERG response enough to affect the full-field ERG, but in some ‘‘macular’’ conditions such as cone dystrophy and X-linked retinoschisis, the fullfield ERG is still needed diagnostically to determine diffuse retinal abnormalities. The pattern ERG is dominated by macular-related activity but provides no topographical information. Likewise, the VEP is dominated by activity from the central visual field but an impaired VEP may be produced by a deficit anywhere along the visual pathway including the retina, optic nerve, and brain. This chapter discusses the utility of electrophysiologic tests in diseases that may be categorized as ‘‘macular disorders.’’ The conditions covered are:
277